In vivo vulnerability to competition by endogenous dopamine: Comparison of the D2 receptor agonist radiotracer (–)‐N‐[11C]propyl‐norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]‐raclopride
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
(–)‐N‐Propyl‐norapomorphine (NPA) is a full dopamine (DA) D 2 receptor agonist and [11 C]NPA is a suitable radiotracer to image D 2 receptors configured in a state of high affinity for agonists with positron emission tomography (PET). In this study the vulnerability of the in vivo binding of [11 C]NPA to acute fluctuation in synaptic DA was assessed with PET in baboons and compared to that of the reference D 2 receptor antagonist radiotracer [11 C]raclopride. Three male baboons were studied with [11 C]raclopride and [11 C]NPA under baseline conditions and following administration of the potent DA releaser amphetamine (0.3, 0.5, and 1.0 mg kg–1 i.v.). Kinetic modeling with an arterial input function was used to derive the striatal specific‐to‐nonspecific equilibrium partition coefficient (V 3″). [11 C]Raclopride V 3″ was reduced by 24 ± 10%, 32 ± 6%, and 44 ± 9% following amphetamine doses of 0.3, 0.5, and 1.0 mg kg–1, respectively. [11 C]NPA V 3″ was reduced by 32 ± 2%, 45 ± 3%, and 53 ± 9% following amphetamine doses of 0.3, 0.5, and 1.0 mg kg–1, respectively. Thus, endogenous DA was more effective at competing with [11 C]NPA binding compared to [11 C]raclopride binding, a finding consistent with the pharmacology of these tracers (agonist vs. antagonist). These results also suggest that 71% of D 2 receptors are configured in a state of high affinity for agonists in vivo. In conclusion, [11 C]NPA might provide a superior radiotracer to probe presynaptic DA function with PET in health and disease. Synapse 52:188–208, 2004. © 2004 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Laruelle, M., Abi-Dargham, A., van Dyck, C. H., Gil, R., D'Souza, C. D., Erdos, J., McCance, E., Rosenblatt, W., Fingado, C., Zoghbi, S. S., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.9235 · Cited by 1,291 · cited 5×
“For example, three studies reported that the reduction in [123I]IBZM or [11C]raclopride binding induced by amphetamine was elevated in schizophrenia (Abi-Dargham et al., 1998; Breier et al., 1997; Laruelle et al., 1996).”
BackgroundMethodResultInfluentialSelf-citationBreier, A., Su, T.-P., Saunders, R., Carson, R. E., Kolachana, B. S., de Bartolomeis, A., Weinberger, D. R., Weisenfeld, N., Malhotra, A. K., Eckelman, W. C., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2569 · Cited by 1,154 · cited 9×
“For example, three studies reported that the reduction in [123I]IBZM or [11C]raclopride binding induced by amphetamine was elevated in schizophrenia (Abi-Dargham et al., 1998; Breier et al., 1997; Laruelle et al., 1996).”
BackgroundMethodResultInfluentialIncreased baseline occupancy of D 2 receptors by dopamine in schizophrenia
Abi-Dargham, A., Rodenhiser, J., Printz, D., Zea-Ponce, Y., Gil, R., Kegeles, L. S., Weiss, R., Cooper, T. B., Mann, J. J., Van Heertum, R. L., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.14.8104 · Cited by 1,020 · cited 2×
“Accounting for the fact that 10% of the total receptor pool were already occupied by DA in the baseline state (Abi-Dargham et al., 2000), 90% of D2 receptors were available to [ 11C]raclopride binding (40% being D2high sites, 50% being D2low sites).”
BackgroundSelf-citationImaging Synaptic Neurotransmission with in Vivo Binding Competition Techniques: A Critical Review
Laruelle, M. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200003000-00001 · Cited by 944
Self-citationAmphetamine-induced dopamine release in human ventral striatum correlates with euphoria
Drevets, W. C., Gautier, C., Price, J. C., Kupfer, D. J., Kinahan, P. E., Grace, A. A., Price, J. L., & Mathis, C. A. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01038-6 · Cited by 706 · cited 3×
“…2004 WILEY-LISS, INC. al., 1997; Dewey et al., 1993; Drevets et al., 1999; Endres et al., 1997; Innis et al., 1992; Laruelle et al., 1997; Tsukada et al., 1999) and humans (Breier et al., 1997; Drevets et al., 2001; Kegeles et al., 1999; Laruelle et al., 1995; Martinez et al., 2003).”
MethodInfluentialMartinez, D., Slifstein, M., Broft, A., Mawlawi, O., Hwang, D.-R., Huang, Y., Cooper, T., Kegeles, L., Zarahn, E., Abi-Dargham, A., et al. (2003) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000048520.34839.1a · Cited by 569
Self-citationMawlawi, O., Martinez, D., Slifstein, M., Broft, A., Chatterjee, R., Hwang, D.-R., Huang, Y., Simpson, N., Ngo, K., Van Heertum, R., et al. (2001) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200109000-00002 · Cited by 525 · cited 3×
“[11C]raclopride and [11C]NPA were prepared as previously described (Hwang et al., 2000; Mawlawi et al., 2001).”
MethodInfluentialSelf-citationBrain SPECT Imaging of Amphetamine-Induced Dopamine Release in Euthymic Bipolar Disorder Patients
Anand, A., Verhoeff, P., Seneca, N., Zoghbi, S. S., Seibyl, J. P., Charney, D. S., & Innis, R. B. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.7.1108 · Cited by 222
Dopamine D2 receptor availability and amphetamine-induced dopamine release in unipolar depression
Parsey, R. V., Oquendo, M. A., Zea-Ponce, Y., Rodenhiser, J., Kegeles, L. S., Pratap, M., Cooper, T. B., Van Heertum, R., Mann, J. J., & Laruelle, M. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01089-7 · Cited by 133 · cited 3×
“This test has been successfully used as a probe of presynaptic DA function in health and disease (Abi-Dargham et al., 1998; Anand et al., 2000; Breier et al., 1997; Laruelle et al., 1996; Parsey et al., 2001; Singer et al., 2002).”
BackgroundMethodSelf-citationPET measures of amphetamine-induced dopamine release in ventral versus dorsal striatum
Drevets, W. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00079-2 · Cited by 122 · cited 2×
“Drevets et al. (1999) reported [11C]raclopride V3 in the putamen of –11% (n 4), –17% (n 4), and –29% (n 4) in baboons following amphetamine doses of 0.3, 0.6, and 1 mg kg–1, respectively.”
BackgroundInfluential
Cited by
Zhang, A., Neumeyer, J. L., & Baldessarini, R. J. (2007) · Chemical Reviews · doi:10.1021/cr050263h · Cited by 428
Sex Differences in Striatal Dopamine Release in Healthy Adults
Munro, C. A., McCaul, M. E., Wong, D. F., Oswald, L. M., Zhou, Y., Brasic, J., Kuwabara, H., Kumar, A., Alexander, M., Ye, W., et al. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.01.008 · Cited by 350
Dysregulation of Endogenous Opioid Emotion Regulation Circuitry in Major Depression in Women
Kennedy, S. E., Koeppe, R. A., Young, E. A., & Zubieta, J.-K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.11.1199 · Cited by 338
Tziortzi, A. C., Haber, S. N., Searle, G. E., Tsoumpas, C., Long, C. J., Shotbolt, P., Douaud, G., Jbabdi, S., Behrens, T. E. J., Rabiner, E. A., et al. (2014) · Cerebral Cortex · doi:10.1093/cercor/bhs397 · Cited by 315
Scott, D. J., Heitzeg, M. M., Koeppe, R. A., Stohler, C. S., & Zubieta, J.-K. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2577-06.2006 · Cited by 297
Metadata
- Authors
- Narendran, R., Hwang, D., Slifstein, M., Talbot, P. S., Erritzoe, D., Huang, Y., Cooper, T. B., Martinez, D., Kegeles, L. S., Abi‐Dargham, A., & Laruelle, M.
- Venue
- Synapse
- Publisher
- Wiley
- Published
- 2004-03-25
- Volume
- 52
- Issue
- 3
- Pages
- 188-208
- ISSN
- 0887-4476 (ISSN-L)
- 1098-2396
- OpenAlex
- W2016678309
- Cited by
- 157
- References
- 11
- FWCI
- 4.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: In vivo vulnerability to competition by endogenous dopamine: Comparison of the D2 receptor agonist radiotracer (–)‐N‐[11C]propyl‐norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]‐raclopride. https://app.cochat.ai/papers/10.1002/syn.20013
- The paper
- Narendran, R., Hwang, D., Slifstein, M., Talbot, P. S., Erritzoe, D., Huang, Y., Cooper, T. B., Martinez, D., Kegeles, L. S., Abi‐Dargham, A., & Laruelle, M. (2004). In vivo vulnerability to competition by endogenous dopamine: Comparison of the D2 receptor agonist radiotracer (–)‐N‐[11C]propyl‐norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]‐raclopride. Synapse. https://doi.org/10.1002/syn.20013
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.